Reversing vemurafenib‐resistance in primary melanoma cells by combined romidepsin and type I <scp>IFN</scp> treatment through blocking of tumorigenic signals and induction of immunogenic effects
Alessandra Fragale(Istituto Superiore di Sanità), Lucia Gabriele(Istituto Superiore di Sanità)
Cited by 10